BW
GNOM icon

Bison Wealth’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bison Wealth’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-255
Closed -$12K – 274
2022
Q2 		$12K Sell
255
-50
-16% -$2.54K 0.01% 282
2022
Q1 		$18K Sell
305
-225
-42% -$14.2K 0.01% 308
2021
Q4 		$42K Sell
530
-50
-9% -$4.2K 0.02% 256
2021
Q3 		$51K Hold
580
– – 0.02% 314
2021
Q2 		$58K Sell
580
-50
-8% -$4.43K 0.03% 309
2021
Q1 		$57K Buy
+630
New +$62.2K 0.02% 313

Other funds holding GNOM

Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bison Wealth's GNOM Position: Q3 2022 in Review

Bison Wealth sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2022, closing a stake of 255 shares — an estimated $12K sold.

Bison Wealth first reported a position in GNOM in Q1 2021 and held it in 6 quarters. The position peaked at $58K in Q2 2021. 58 funds tracked by Wall St. Rank hold GNOM as of Q3 2022.

  • Bison Wealth reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
  • Bison Wealth sold 255 Global X Genomics & Biotechnology ETF shares in Q3 2022, an estimated $12K.
  • Bison Wealth first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 6 quarters.
  • Bison Wealth's Global X Genomics & Biotechnology ETF position peaked at $58K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2022.

Based on Bison Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.